AstraZeneca’s Tagrisso, chemo combination shows promise in lung cancer trial, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The trial was on patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer., The trial was on patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer., , Read More